Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

433830

registered interest
date	01/12/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Vaccine Damage Payment Scheme
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he has made of the effectiveness of the Vaccine Damage Payment scheme.
tabling member constituency	York Outer
tabling member printed	Julian Sturdy
uin	902566
answer	answer is ministerial correction date of answer 07/12/2015 answer text <p>Policy responsibility for the Vaccine Damage Payment Scheme transferred to the Department of Health from the Department for Work and Pensions (DWP) in May 2014 although DWP continues to administer this scheme. The scheme was last revised in 2007 and no assessment of effectiveness has been made since that date.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 07/12/2015 13:53:40 answering member 3918 label Biography information for Jane Ellison
tabling member	4079 label Biography information for Julian Sturdy

436266

registered interest
date	08/12/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Lumacaftor/ivacaftor
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, when he expects Orkambi to be appraised by NICE.
tabling member constituency	York Outer
tabling member printed	Julian Sturdy
uin	19234
answer	answer is ministerial correction date of answer 15/12/2015 answer text <p>The National Institute for Health and Care Excellence (NICE) is currently developing technology appraisal guidance on the use of Orkambi (lumacaftor in combination with ivacaftor) for the treatment of cystic fibrosis in people who are homozygous for the F508del mutation. NICE’s anticipated publication date for this guidance is July 2016. Further information is available at:</p><br /><p>www.nice.org.uk/guidance/indevelopment/gid-tag530</p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 15/12/2015 16:20:22 answering member 4020 label Biography information for George Freeman
tabling member	4079 label Biography information for Julian Sturdy

436267

registered interest
date	08/12/2015
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what representations he has received on reforming of NICE's procedure for appraisal of medicines.
tabling member constituency	York Outer
tabling member printed	Julian Sturdy
uin	19235
answer	answer is ministerial correction date of answer 15/12/2015 answer text <p>We receive representations about the National Institute for Health and Care Excellence’s (NICE) technology appraisal programme from hon. Members, members of the public, clinicians and the pharmaceutical industry.</p><br /><p>NICE is the independent body that provides guidance on the prevention and treatment of ill health and the promotion of good health and social care and is responsible for its own processes and methodology.</p><br /><p>NICE regularly reviews these and its internationally renowned technology appraisal programme has evolved constantly to meet new challenges. NICE has demonstrated its ability to adapt to changes in the health and care environment, and we expect it will continue to evolve in the future, in particular through the recommendations of the Accelerated Access Review which NICE is centrally involved in.</p><br /><p>Further guidance on NICE’s processes of technology appraisal is available at:</p><br /><p>www.nice.org.uk/article/pmg19/chapter/Foreword</p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 15/12/2015 16:28:02 answering member 4020 label Biography information for George Freeman
tabling member	4079 label Biography information for Julian Sturdy

456540

registered interest
date	01/03/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Pharmacy: Closures
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what recent discussions he has held with pharmacy patients on the closure of community pharmacies.
tabling member constituency	York Outer
tabling member printed	Julian Sturdy
uin	29298
answer	answer is ministerial correction date of answer 07/03/2016 answer text <p>Community pharmacy is a vital part of the National Health Service and can play an even greater role. In the Spending Review the Government re-affirmed the need for the NHS to deliver £22 billion in efficiency savings by 2020/21 as set out in the NHS’s own plan, the Five Year Forward View. Community pharmacy is a core part of NHS primary care and has an important contribution to make as the NHS rises to these challenges. The Government believes efficiencies can be made without compromising the quality of services or public access to them. Our aim is to ensure that those community pharmacies upon which people depend continue to thrive and so we are consulting on the introduction of a Pharmacy Access Scheme, which will provide more NHS funds to certain pharmacies compared to others, considering factors such as location and the health needs of the local population.</p><p> </p><p>The Government’s vision is for a more efficient, modern system that will free up pharmacists to spend more time delivering clinical and public health services to the benefit of patients and the public.</p><p> </p><p>Our proposals are about improving services for patients and the public and securing efficiencies and savings. A consequence may be the closure of some pharmacies but that is not our aim. We are not able to assess which pharmacies may close or the number of people who may lose their jobs, because we do not know the financial viability of individual businesses or the extent to which they derive income from services commissioned locally by the NHS or local authorities or have non-NHS related income.</p><p> </p><p>We are consulting the Pharmaceutical Services Negotiating Committee and others, including patient and public representatives on our proposals. An impact assessment will be completed to inform final decisions and published in due course.</p><p> </p><p> </p><p> </p><p> </p> answering member constituency North East Bedfordshire answering member printed Alistair Burt grouped question UIN 29299 question first answered 07/03/2016 12:32:46 answering member 1201 label Biography information for Alistair Burt
tabling member	4079 label Biography information for Julian Sturdy

456541

registered interest
date	01/03/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Pharmacy: Impact Assessments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he has made of the effect of proposals for changes to Government policy on community pharmacies.
tabling member constituency	York Outer
tabling member printed	Julian Sturdy
uin	29299
answer	answer is ministerial correction date of answer 07/03/2016 answer text <p>Community pharmacy is a vital part of the National Health Service and can play an even greater role. In the Spending Review the Government re-affirmed the need for the NHS to deliver £22 billion in efficiency savings by 2020/21 as set out in the NHS’s own plan, the Five Year Forward View. Community pharmacy is a core part of NHS primary care and has an important contribution to make as the NHS rises to these challenges. The Government believes efficiencies can be made without compromising the quality of services or public access to them. Our aim is to ensure that those community pharmacies upon which people depend continue to thrive and so we are consulting on the introduction of a Pharmacy Access Scheme, which will provide more NHS funds to certain pharmacies compared to others, considering factors such as location and the health needs of the local population.</p><p> </p><p>The Government’s vision is for a more efficient, modern system that will free up pharmacists to spend more time delivering clinical and public health services to the benefit of patients and the public.</p><p> </p><p>Our proposals are about improving services for patients and the public and securing efficiencies and savings. A consequence may be the closure of some pharmacies but that is not our aim. We are not able to assess which pharmacies may close or the number of people who may lose their jobs, because we do not know the financial viability of individual businesses or the extent to which they derive income from services commissioned locally by the NHS or local authorities or have non-NHS related income.</p><p> </p><p>We are consulting the Pharmaceutical Services Negotiating Committee and others, including patient and public representatives on our proposals. An impact assessment will be completed to inform final decisions and published in due course.</p><p> </p><p> </p><p> </p><p> </p> answering member constituency North East Bedfordshire answering member printed Alistair Burt grouped question UIN 29298 question first answered 07/03/2016 12:32:47 answering member 1201 label Biography information for Alistair Burt
tabling member	4079 label Biography information for Julian Sturdy

458532

registered interest
date	08/03/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Lipoedema
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, if he will implement a treatment pathway for people who suffer from lipoedema to allow such people to receive liposuction on the NHS.
tabling member constituency	York Outer
tabling member printed	Julian Sturdy
uin	30284
answer	answer is ministerial correction date of answer 15/03/2016 answer text <p>There are several different treatments available for the management of lipoedema such as compression therapy, exercise and massage. There is limited evidence on the efficacy of liposuction for the treatment of lipoedema, and it is not routinely available on the National Health Service.</p> answering member constituency Battersea answering member printed Jane Ellison question first answered 15/03/2016 11:19:17 answering member 3918 label Biography information for Jane Ellison
tabling member	4079 label Biography information for Julian Sturdy

652693

registered interest
date	06/12/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he has made of the potential merits of the use of portable surgical health centres to support (a) the delivery of care in a community setting, (b) system transformation and efficiency within the NHS and (c) improving patient outcomes.
tabling member constituency	York Outer
tabling member printed	Julian Sturdy
uin	56252
answer	answer is ministerial correction date of answer 13/12/2016 answer text <p>It is for commissioners to determine the most appropriate model of care provision to meet the needs of their local populations and provide the highest quality of care, which may include the use of portable surgical health centres.</p> answering member constituency Ludlow answering member printed Mr Philip Dunne question first answered 13/12/2016 15:27:12 answering member 1542 label Biography information for Philip Dunne
tabling member	4079 label Biography information for Julian Sturdy

657934

registered interest
date	13/12/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Mental Health Services: Children and Young People
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps the Government is taking to help ensure that appointment waiting times at child and adolescent mental health services in England are being reduced.
tabling member constituency	York Outer
tabling member printed	Julian Sturdy
uin	57397
answer	answer is ministerial correction date of answer 19/12/2016 answer text <p>The Department does not currently collect information on waiting times for all child and adolescent mental health services.</p><p> </p><p>However, we have introduced the first ever access and waiting time standards for mental health. Standards on waiting times for early intervention in psychosis are already in place and encompass children and young people aged 14 or over. Standards for eating disorders services, targeted at children and young people, were published in August 2015 and will come into effect on 1 April 2017.</p><p> </p><p>In addition, NHS Digital has begun publishing experimental data from the Data Set setting out the waiting times of children and young people between referral and second contact. NHS England has also set aside a fund of £25 million to reduce waiting times backlogs and asked clinical commissioning groups to set out the steps they will make, using that fund, to reduce any waiting lists during 2016-17.</p> answering member constituency Oxford West and Abingdon answering member printed Nicola Blackwood grouped question UIN 57398 question first answered 19/12/2016 15:19:58 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	4079 label Biography information for Julian Sturdy

657937

registered interest
date	13/12/2016
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Mental Health Services: Children and Young People
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what information his Department holds on regional appointment waiting times for child and adolescent mental health services in England.
tabling member constituency	York Outer
tabling member printed	Julian Sturdy
uin	57398
answer	answer is ministerial correction date of answer 19/12/2016 answer text <p>The Department does not currently collect information on waiting times for all child and adolescent mental health services.</p><p> </p><p>However, we have introduced the first ever access and waiting time standards for mental health. Standards on waiting times for early intervention in psychosis are already in place and encompass children and young people aged 14 or over. Standards for eating disorders services, targeted at children and young people, were published in August 2015 and will come into effect on 1 April 2017.</p><p> </p><p>In addition, NHS Digital has begun publishing experimental data from the Data Set setting out the waiting times of children and young people between referral and second contact. NHS England has also set aside a fund of £25 million to reduce waiting times backlogs and asked clinical commissioning groups to set out the steps they will make, using that fund, to reduce any waiting lists during 2016-17.</p> answering member constituency Oxford West and Abingdon answering member printed Nicola Blackwood grouped question UIN 57397 question first answered 19/12/2016 15:19:58 answering member 4019 label Biography information for Baroness Blackwood of North Oxford
tabling member	4079 label Biography information for Julian Sturdy

768122

registered interest
date	10/10/2017
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Blood: Contamination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he has made of progress on the Government's plans to provide justice to those affected by contaminated blood products.
tabling member constituency	York Outer
tabling member printed	Julian Sturdy
uin	106945
answer	answer is ministerial correction date of answer 17/10/2017 answer text <p>The Government is consulting on the scope, format and sponsorship of the inquiry into contaminated blood until 18 October 2017. The Government will provide a further update to the House after the consultation closes.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 17/10/2017 12:38:54 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4079 label Biography information for Julian Sturdy